Icon
+91 94997 68112
Login Register

Trilipix - (135mg, 45mg; Capsule Delayed release oral)

Fenofibrate Choline Abbvie
135mg, 45mg; Capsule Delayed release oral
Less Than $1000 mn
Less Than 5
Less Than 5
Less Than 5
 None
More Than 5
More Than 5
Trilipix is a peroxisome proliferator-activated receptor (PPAR) alpha agonist indicated as adjunctive therapy to diet to: • Reduce TG in patients with severe hypertriglyceridemia. • Reduce elevated LDL-C, Total-C, TG and Apo B, and to increase HDL-C in patients with primary hypercholesterolemia or mixed dyslipidemia
Yes
***** *** *** ***** ** **** **** ** **** ****** ******* ******** ** * *** ****. ******* ******, *****, ***** *** ******* ***** ****** *********** ****** '*** *** **** ************ *********. ****** ** ****** **** ****** ****** & ***** ******* * ********** ********* ** ***** ***** *** ****** *** ******* ** ***. *, **** ** ** ***** ** **** **, **** ***** ******* *************. ***** ********** *** ******* **** ****** (*******), ***** *** ***** ** ****, ***** *** ********* ******** *** ******* ****** *** ****** ***** *****. ***** ******** *** ******* ** ********** *******. ******* *** ** ****** *** **** *** ******** ** *** **** ****** ******** *******. ***** ** ******** ******** **% ** **** *** ** ******* ***** *** ****** *** ********. ***** ****** *** ********* *** *** **** ** **** ****** '***, ******* *** ********** *** ********* ***** *** ***** ** ********* *** *** ***** *** ****** *** *** ******** *** ******* ***. ***** ** ** ******* ** ****** '*** *** ** ** ***** ***** ** *** ****** **** ** *** ********* ***** ******** *** *** **** ** ******. **** ** * ******* *********** ******* ***** ** *** **********.
  1. ***, **** : ***** ******** ****** ***** *** **** ** *** **** & ***** ********, ** ****** '***.
  2. ***, **** : ***** ******** ****** ***** *** **** ** *** ** *** ***** ******** ** ****** ***'.
  3. ***, **** : ****** ***** **** ******* ***** ** ******** ***** ** **.
  4. ***, **** : ****** ******** ****** ***** *** **** ** *** ** *** ***** ******** ** ****** ***'.
  5. *****, **** : ***** **** ****** ** ******** ***** ** *** ******.
  6. ***, **** : ****** **** ***** ** ******** ***** ** **
  7. *****, **** : ****** **** ***** *** ****** (** ******** ***** ** ********* *******).
  8. *****, **** : ******* ******** ****** ***** ****** ** *** **** *** ** *** ***** *** ****** *** ** ******** ***** ** **.
  9. *****, **** : ****** **** *******.
  10. *** **, **** : ****** & ***** ******* * ********** ********* ** ***** ***** *** ****** *** ******* ** ***. *, **** ** ** ***** ** **** **, **** ***** ******** *************.
  11. *** **, **** : *** *** ********** ** *** **** ********* *** **** ***** * ***** *** ******* ********* ** ********** *** ***-************ ** ****** '***.
  12. *** **, **** : ********** ****** *** ******* ********* *** ******.
  13. **** **, **** : ****** **** ******* **** ******, ***** *** *****.
  14. *** **, **** : ***** ***** * **** ******* ****** ** ****** ***** **** ** **** ****** '***.
  15. *** **, **** : ********** *** ********* **** ****** ***** *** ***** ** ********* *** *** *****.

Download ParaIV Report

Download ParaIV Detailed Report

To get detailed report Contact Us

ParaIV Advanced Search






Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.